77 related articles for article (PubMed ID: 10366566)
1. Tetracycline-mediated regulation of gene expression within the human cytomegalovirus genome.
McVoy MA; Mocarski ES
Virology; 1999 Jun; 258(2):295-303. PubMed ID: 10366566
[TBL] [Abstract][Full Text] [Related]
2. Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor.
Ghersa P; Gobert RP; Sattonnet-Roche P; Richards CA; Merlo Pich E; Hooft van Huijsduijnen R
Gene Ther; 1998 Sep; 5(9):1213-20. PubMed ID: 9930322
[TBL] [Abstract][Full Text] [Related]
3. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells.
Freundlieb S; Schirra-Müller C; Bujard H
J Gene Med; 1999; 1(1):4-12. PubMed ID: 10738580
[TBL] [Abstract][Full Text] [Related]
4. Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness.
Agha-Mohammadi S; O'Malley M; Etemad A; Wang Z; Xiao X; Lotze MT
J Gene Med; 2004 Jul; 6(7):817-28. PubMed ID: 15241789
[TBL] [Abstract][Full Text] [Related]
5. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.
Furth PA; St Onge L; Böger H; Gruss P; Gossen M; Kistner A; Bujard H; Hennighausen L
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9302-6. PubMed ID: 7937760
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal.
Yoshida Y; Hamada H
Biochem Biophys Res Commun; 1997 Jan; 230(2):426-30. PubMed ID: 9016796
[TBL] [Abstract][Full Text] [Related]
7. HSV-1 infected cell proteins influence tetracycline-regulated transgene expression.
Herrlinger U; Pechan PA; Jacobs AH; Woiciechowski C; Rainov NG; Fraefel C; Paulus W; Reeves SA
J Gene Med; 2000; 2(5):379-89. PubMed ID: 11045432
[TBL] [Abstract][Full Text] [Related]
8. Highly efficient regulation of gene expression by tetracycline in a replication-defective herpes simplex viral vector.
Yao F; Theopold C; Hoeller D; Bleiziffer O; Lu Z
Mol Ther; 2006 Jun; 13(6):1133-41. PubMed ID: 16574491
[TBL] [Abstract][Full Text] [Related]
9. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
[TBL] [Abstract][Full Text] [Related]
10. The use of recombinant baculoviruses for sustained expression of human cytomegalovirus immediate early proteins in fibroblasts.
Dwarakanath RS; Clark CL; McElroy AK; Spector DH
Virology; 2001 Jun; 284(2):297-307. PubMed ID: 11384228
[TBL] [Abstract][Full Text] [Related]
11. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
[TBL] [Abstract][Full Text] [Related]
12. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette.
Hofmann A; Nolan GP; Blau HM
Proc Natl Acad Sci U S A; 1996 May; 93(11):5185-90. PubMed ID: 8643550
[TBL] [Abstract][Full Text] [Related]
13. Tetracycline-inducible gene expression and gene deletion in Candida albicans.
Park YN; Morschhäuser J
Eukaryot Cell; 2005 Aug; 4(8):1328-42. PubMed ID: 16087738
[TBL] [Abstract][Full Text] [Related]
14. Expression of highly controllable genes in insect cells using a modified tetracycline-regulated gene expression system.
Wu TY; Liono L; Chen SL; Chen CY; Chao YC
J Biotechnol; 2000 Jun; 80(1):75-83. PubMed ID: 10862988
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the relative luciferase activity in secondary CEF by different heterogenous strong promoters, MDV gB promoter and the composed promoters].
Qiu YF; Ge FF; Xu XQ; Chen PY
Wei Sheng Wu Xue Bao; 2006 Apr; 46(2):314-7. PubMed ID: 16736599
[TBL] [Abstract][Full Text] [Related]
16. Stringent and reproducible tetracycline-regulated transgene expression by site-specific insertion at chromosomal loci with pre-characterised induction characteristics.
Brough R; Papanastasiou AM; Porter AC
BMC Mol Biol; 2007 May; 8():30. PubMed ID: 17493262
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
18. Optimization of tetracycline-responsive recombinant protein production and effect on cell growth and ER stress in mammalian cells.
Jones J; Nivitchanyong T; Giblin C; Ciccarone V; Judd D; Gorfien S; Krag SS; Betenbaugh MJ
Biotechnol Bioeng; 2005 Sep; 91(6):722-32. PubMed ID: 15981277
[TBL] [Abstract][Full Text] [Related]
19. Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region.
Xiao Y; Kuwata T; Miura T; Hayami M; Shida H
Virology; 2000 Apr; 269(2):268-75. PubMed ID: 10753705
[TBL] [Abstract][Full Text] [Related]
20. The human cytomegalovirus-encoded receptor US28 increases the activity of the major immediate-early promoter/enhancer.
Boomker JM; The TH; de Leij LF; Harmsen MC
Virus Res; 2006 Jun; 118(1-2):196-200. PubMed ID: 16448715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
